Observational Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Nov 18, 2022; 12(11): 378-387
Published online Nov 18, 2022. doi: 10.5500/wjt.v12.i11.378
Parvovirus B19 status in liver, kidney and pancreas transplant candidates: A single center experience
Bojana Simunov, Anna Mrzljak, Zeljka Jurekovic, Snjezana Zidovec Lepej, Ana Bainrauch, Jadranka Pavicic Saric, Zeljka Hruskar, Leona Radmanic, Tatjana Vilibic-Cavlek
Bojana Simunov, Zeljka Jurekovic, Department of Nephrology, Merkur University Hospital, Zagreb 10000, Croatia
Anna Mrzljak, Department of Gastroenterology and Hepatology, University Clinical Hospital Zagreb, Zagreb 10000, Croatia
Anna Mrzljak, Tatjana Vilibic-Cavlek, School of Medicine, University of Zagreb, Zagreb 10000, Croatia
Snjezana Zidovec Lepej, Leona Radmanic, Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Zagreb 10000, Croatia
Ana Bainrauch, Department of Medicine, Merkur University Hospital, Zagreb 10000, Croatia
Jadranka Pavicic Saric, Department of Anesthesiology, Merkur University Hospital, Zagreb 10000, Croatia
Zeljka Hruskar, Tatjana Vilibic-Cavlek, Department of Virology, Croatian Institute of Public Health, Zagreb 10000, Croatia
Author contributions: Simunov B contributed to the concept of the study, collected and analyzed the data, and wrote the original draft; Jurekovic Z, Zidovec Lepej S, Bainaruch A, Pavicic Saric J, Hruskar Z, and Radmanic L analyzed the data; Mrzljak A and Vilibic-Cavlek T made contributions to the concept of the study, and revised the manuscript critically; all authors approved the final version of the manuscript.
Supported by the Croatian Science Foundation Project, No. IP-2020-02-7407.
Institutional review board statement: The study was reviewed and approved by the Ethic Committee of the School of Medicine University of Zagreb (Approval No. 641-01/20-02/01).
Informed consent statement: Written informed consent was obtained from all participants included in the study.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Data sharing statement: No data sharing available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Anna Mrzljak, MD, PhD, Professor, Department of Gastroenterology and Hepatology, University Clinical Hospital Zagreb, 12 Kispaticeva, Zagreb 10000, Croatia. anna.mrzljak@gmail.com
Received: July 24, 2022
Peer-review started: July 24, 2022
First decision: August 22, 2022
Revised: September 5, 2022
Accepted: September 22, 2022
Article in press: September 22, 2022
Published online: November 18, 2022
Processing time: 115 Days and 9.5 Hours
Core Tip

Core Tip: Many liver, kidney, or pancreas transplant recipients are parvovirus B19 seronegative and at risk for primary disease and severe manifestations. Serological studies on pretransplant could simplify the diagnostic work-up of anemia after transplantation in these complex patients.